RE:I'm shaking my head
i cant understand anybody selling for less than .65...$100 million is the minum this stock should be trading at. truthfully more like $200 million.
on their corporate presentation they say this drug has $400 million global revenue potential...so if Endo gave them $25 million up front plus $125 million in milestones plus a 12% royalty plus pay for phase 3 for $50-100 million...what are all those numbers now without having to do another phase 3 trial??? and 5 yeears sooner!!
who are the fools selling at .28 or even .30? this should end the day a double (over .32) and then double next week too